This inventor holds 1 USPTO granted patent. Top assignee: Biogen, Incorporated. Active years: 1990.
Company Filing History:
Years Active: 1990
Title: Mo-Quen Klinkert: Innovator in Swine Mycoplasma Research
Introduction
Mo-Quen Klinkert is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of veterinary medicine, particularly in the area of swine health. His work focuses on developing solutions to combat mycoplasma infections in swine herds.
Latest Patents
Klinkert holds a patent for "DNA sequences coding for Mycoplasma hypopneumoniae surface antigens." This patent includes surface antigens of swine mycoplasma, which are prepared using recombinant DNA methods. It also covers a swine mycoplasma vaccine based on these antigens, methods for treating swine to prevent enzootic pneumonia using the vaccine, and diagnostic tests for detecting swine mycoplasma infections. The patent highlights the importance of these DNA sequences in advancing swine health.
Career Highlights
Klinkert is currently associated with Biogen, Incorporated, where he continues to work on innovative solutions for swine health. His research has been pivotal in understanding and addressing mycoplasma-related diseases in livestock.
Collaborations
Klinkert collaborates with various professionals in his field, including his coworker Heinz E Schaller. Their combined expertise contributes to the advancement of veterinary science and the development of effective treatments for swine diseases.
Conclusion
Mo-Quen Klinkert's contributions to the field of veterinary medicine, particularly through his patent on mycoplasma antigens, demonstrate his commitment to improving swine health. His work is essential for the advancement of veterinary practices and the welfare of livestock.